Search This Blog

Wednesday, June 6, 2018

Sage started at buy by Ladenburg


Sage Therapeutics initiated with a Buy at Ladenburg. Ladenburg Thalmann analyst Michael Higgins started Sage Therapeutics with a Buy rating and $230 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)